The NSW Government today launched the country’s first cannabis medicines hotline in an effort to fast-track patient access, and provide more support to their doctors.
The Commonwealth Therapeutic Goods Administration (TGA) today released a summary for patients about the national review of the scientific evidence for the use of cannabis medicines in five areas: palliative care, nausea and vomiting, epilepsy, multiple sclerosis and pain.
The NSW Government is intent on getting more patients access to medicinal cannabis products for palliative care, under a $6 million statewide advisory service aimed at supporting doctors.
The Turnbull Government will seek parliamentary support to allow the controlled cultivation of cannabis for medicinal or scientific purposes in Australia to deliver patients access to a safe, legal and sustainable supply of locally-produced products for the first-time.
Parliament has today passed the Turnbull Government’s historic legislation delivering the “missing piece” for Australian patients and their doctors to access a safe, legal and reliable supply of medicinal cannabis products for the management of painful and chronic conditions.
To the desperate parent I would say: “I am not certain that cannabidiol will help your child, in fact, it is most likely that it won’t have a big benefit.”
Researchers are now recruiting palliative care cancer patients in Sydney and Newcastle for Australia’s first clinical trial of vaporised cannabis flower bud.
Doctors are now recruiting patients in a world-first medicinal cannabis trial in NSW for the prevention of chemotherapy-induced nausea and vomiting.
Despite dozens of trials internationally, the evidence on medical cannabis is unconvincing.
You may think you know what a cannabis plant looks like, but even experts are still learning about how one plant may differ from the next in its chemical profile.
A group of children in the Hunter New England region have begun receiving doses of pharmaceutical-grade, cannabis-derived medicine to treat severe, treatment-resistant epilepsy under the NSW Government’s Compassionate Access Scheme for Epidiolex®, led by Sydney Children’s Hospitals Network.
The scheduling delegate has released final decisions on the scheduling of cannabis and tetrahydrocannabinols. This content exists on an external website. Click to read the article in a new window.
Some of the state’s sickest children have begun receiving doses of pharmaceutical-grade, cannabis-derived medicine to treat severe, drug-resistant epilepsy under the NSW Government’s Compassionate Access Scheme for Epidiolex®.
Doctors in NSW will now be able to apply to prescribe a broader range of cannabis-based medicines as a result of NSW Government regulatory changes.
NSW has become the first Australian state authorised by the Commonwealth Government to conduct medicinal cannabis cultivation research, bringing a local pharmaceutical supply one step closer.
In an Australian first, NSW children with severe treatment-resistant epilepsy will be provided with compassionate access to Epidiolex®
The NSW Government continues to advance medical research in NSW through investment in the 2016-17 Budget.
Innovation, cyber security and cutting-edge medical and financial services technologies will form the focus of a visit to Israel next week by NSW Premier Mike Baird.
NSW Premier Mike Baird and Minister for Medical Research Pru Goward today announced the third medicinal cannabis clinical trial, which will involve patients with chemotherapy-induced nausea and vomiting.
This Media Release exists on an external website. Click to read the article in a new window.
NSW Minister for Medical Research Pru Goward has congratulated the Commonwealth Government on introducing legislation to establish a national licensing scheme for the controlled cultivation of cannabis for medical and related scientific purposes into federal parliament today.
The NSW and Tasmanian Governments will team up to further improve our understanding of the therapeutic benefits of medicinal cannabis in providing relief for people suffering from a range of serious illnesses.
Doctors, academics and patient welfare advocates have been appointed to a special advisory council to guide the NSW Government’s world-leading medicinal cannabis research program.
NSW Premier Mike Baird and Minister for Medical Research Pru Goward today announced that a Memorandum of Understanding (MOU) has been signed with GW Pharmaceuticals (GW) to progress a major new research program for cannabis-based medicines in children with severe, drug resistant childhood epilepsy.
NSW Minister for Medical Research Pru Goward and NSW Minister for Primary Industries Niall Blair today joined the Federal Minister for Health the Hon. Sussan Ley MP in Sydney to welcome the Federal Government’s announcement to allow controlled cultivation of cannabis for medicinal or scientific purposes.
NSW continues to position itself as a world leader in cannabis research with the announcement of Australia’s first medical cannabis trial for terminally ill adults by Premier Mike Baird and Minister for Medical Research Pru Goward today.
Media inquiries: cmcri@moh.health.nsw.gov.au
